ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,194Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 780

$882K Total Retail Price of All Prescriptions

Rank: 99 out of 780

861 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 861 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 861 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 14,245 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 735 625 1 3
SIMVASTATIN 686 592 2 2
AMLODIPINE BESYLATE 650 545 3 4
HYDROCODONE-ACETAMINOPHEN 603 383 S3 4 1
LEVOTHYROXINE SODIUM 578 530 5 5
FUROSEMIDE 399 342 6 7
METFORMIN HCL 307 233 7 8
ATORVASTATIN CALCIUM 305 254 8 12
WARFARIN SODIUM 299 275 9 24
LOSARTAN POTASSIUM 291 272 10 18
DONEPEZIL HCL 290 290 11 31
POTASSIUM CHLORIDE 256 207 12 11
MELOXICAM 249 216 13 16
CARVEDILOL 240 188 14 14
NAMENDA 235 209 15 46
QUETIAPINE FUMARATE 230 223 16 81
ZOLPIDEM TARTRATE 223 195 17 17
LISINOPRIL 185 156 18 6
GABAPENTIN 185 154 18 13
MIRTAZAPINE 184 179 20 58
CITALOPRAM HBR 176 139 21 23
LOSARTAN-HYDROCHLOROTHIAZIDE 169 142 22 33
METOPROLOL SUCCINATE 167 147 23 20
PRAVASTATIN SODIUM 156 139 24 9
ALLOPURINOL 155 139 25 29
TRAMADOL HCL 147 116 26 15
ESCITALOPRAM OXALATE 144 95 27 61
CLOPIDOGREL 141 102 28 34
TAMSULOSIN HCL 138 114 29 36
NEXIUM 137 93 30 22
CELEBREX 134 129 31 89
GEMFIBROZIL 133 106 32 104
HYDROCHLOROTHIAZIDE 130 116 33 10
SERTRALINE HCL 128 103 34 27
DIGOXIN 127 118 35 56
FAMOTIDINE 123 111 36 86
TRAZODONE HCL 120 100 37 35
METOPROLOL TARTRATE 119 105 38 19
ENALAPRIL MALEATE 118 112 39 64
TORSEMIDE 117 84 40 114
PLAVIX 116 90 41 45
GLYBURIDE 115 88 R 42 101
ATENOLOL 114 112 43 21
AMLODIPINE BESYLATE-BENAZEPRIL 111 92 44 50
GLIMEPIRIDE 106 88 45 30
SEROQUEL 105 105 46 172
CRESTOR 102 73 47 32
CLONIDINE HCL 94 71 48 28
FLUTICASONE PROPIONATE 91 62 49 41
NOVOLIN R 86 67 50 212
BYSTOLIC 86 81 50 118
LANTUS 86 69 50 71
PANTOPRAZOLE SODIUM 86 62 50 25
LYRICA 81 77 54 52
BISOPROLOL-HYDROCHLOROTHIAZIDE 81 74 54 95
MUPIROCIN 80 62 56 173
EXELON 79 66 57 132
PAROXETINE HCL 77 68 58 69
SPIRONOLACTONE 75 59 59 53
LEVETIRACETAM 74 58 60 130
PREDNISONE 68 56 61 40
CARBIDOPA-LEVODOPA 68 68 61 124
INSULIN SYRINGE 66 35 63 80
DIOVAN 66 48 63 55
METOCLOPRAMIDE HCL 64 37 65 102
LANSOPRAZOLE 62 52 66 184
TRIAMTERENE-HCTZ 60 50 67 37
CEFUROXIME 59 46 68 147
HUMULIN R 59 50 68 228
SANTYL 59 53 68 311
VENLAFAXINE HCL ER 58 25 71 117
GLIPIZIDE 56 44 72 74
DIVALPROEX SODIUM 55 43 73 119
FOSINOPRIL SODIUM 55 29 73 112
MECLIZINE HCL 55 32 73 83
GLYBURIDE-METFORMIN HCL 53 49 R 76 108
ROPINIROLE HCL 53 40 76 87
AZITHROMYCIN 52 46 78 38
BACLOFEN 52 44 78 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.